Airway sensory nerve and tachykinins in asthma and COPD;Die sensible atemwegsinnervation und die tachykinine bei asthma und chronisch-obstruktiver lungenerkrankung (COPD)

Pneumologie

Volumn 60, Issue 2, 2006, Pages 80-85

  Dinh, Q Thai ^a   Klapp, B F ^a   Fischer, A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BRADYKININ; CALCITONIN; CAPSAICIN; DIPEPTIDYL CARBOXYPEPTIDASE; DYNORPHIN; ENKEPHALIN; HISTAMINE; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ A; NEUROPEPTIDE; NEUROPEPTIDE GAMMA; OZONE; PROSTAGLANDIN; PROTEINASE; SODIUM CHLORIDE; SUBSTANCE P; TACHYKININ; TOBACCO SMOKE;

AIRWAY; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; NEUROGENIC INFLAMMATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SENSORY NERVE;

ASTHMA; HUMANS; MUSCLE, SMOOTH; PULMONARY CIRCULATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYSTEM; TACHYKININS;

EID: 33644650495     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-915587     Document Type: Review

References (53)

1. Barnes PJ. Asthma as an axon reflex. Lancet 1986; 1 (8475): 242-245
2. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004; 56 (4): 515-548
3. Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev 1998; 50 (4): 515-596
4. Eynott PR, Groneberg DA, Caramori G et al. Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness. Eur J Pharmacol 2002; 452(1): 123-133
5. Eynott PR, Paavolainen N, Groneberg DA et al. Role of nitric oxide in chronic allergen-induced airway cell proliferation and inflammation. J Pharmacol Exp Ther 2003; 304 (1): 22-29
6. Joos GF, Pauwels RA et al. Tachykinin receptor antagonists: potential in airways diseases. Curr Opin Pharmacol 2001; 1 (3): 235-241
7. Willis T. Opera omnia 1681; Band II. Sect. 1, Cap. XI
8. Kummer W, Fischer A, Kurkowski R et al. The sensory and sympathetic innervation of guinea-pig lung and trachea as studied by retrograde neuronal tracing and double-labelling immunohistochemistry. Neuroscience 1992; 49 (3): 715-737
9. Fischer A, McGregor GP, Saria A et al. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest 1996; 98 (10): 2284-2291
10. Dalsgaard CJ, Lundberg JM. Evidence for a spinal afferent innervation of the guinea pig lower respiratory tract as studied by the horseradish peroxidase technique. Neurosci Lett 1984; 45(2): 117-122
11. Springall DR, Cadieux A, Oliveira H et al. Retrograde tracing shows that CGRP-immunoreactive nerves of rat trachea and lung originate from vagal and dorsal root ganglia. J Auton Nerv Syst 1987; 20: 155-166
12. Saria A, Martling CR, Yan Z et al. Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am Rev Respir Dis 1988; 137 (6): 1330-1335
13. Coleridge JC, Coleridge HM. Afferent vagal C fibre innervation of the lungs and airways and its functional significance. Rev Physiol Biochem Pharmacol 1984; 99: 1-110
14. Ricco MM, Kummer W, Biglari B et al. Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways. J Physiol 1996; 496 (Pt 2): 521-530
15. Stretton D. Non-adrenergic, non-cholinergic neural control of the airways [editorial]. Clin Exp Pharmacol Physiol 1991; 18 (10): 675-684
16. Verastegui C, Prada Oliveira A, Fernandez-Vivero J et al. Calcitonin gene-related peptide immunoreactivity in adult mouse lung. Eur J Histochem 1997; 41 (2): 119-126
17. Fischer A, Folkerts G, Geppetti P et al. Mediators of asthma: nitric oxide. Pulm Pharmacol Ther 2002; 15 (2): 73-81
18. Springer J, Geppetti P, Fischer A et al. Calcitonin gene-related peptide as inflammatory mediator. Pulm Pharmacol Ther 2003; 16 (3): 121-130
19. Karlsson JA, Finney MJ, Persson CG et al. Substance P antagonists and the role of tachykinins in non-cholinergic bronchoconstriction. Life Sci 1984; 35 (26): 2681-2691
20. Li CG, Rand MJ. Evidence that part of the NANC relaxant response of guinea-pig trachea to electrical field stimulation is mediated by nitric oxide. Br J Pharmacol 1991; 102(1): 91-94
21. Lundberg JM, Hokfelt T, Martling CR et al. Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res 1984; 235 (2): 251-261
22. Euler US, Gaddum JH. An unidentified depressor substance in certain tissue extracts. J Physiol 1931; 72: 74-87
23. Chang MM, Leeman SE, Niall HD. Amino-acid sequence of substance P. Nat New Biol 1971; 232 (29): 86-87
24. Tatemoto K, Lundberg JM, Jornvall H et al. Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin. Biochem Biophys Res Commun 1985; 128 (2): 947-953
25. Harmar AJ, Hyde V, Chapman K. Identification and cDNA sequence of delta-preprotachykinin, a fourth splicing variant of the rat substance P precursor. FEBS Lett 1990; 275 (1-2): 22-24
26. Nawa H, Hirose T, Takashima H et al. Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor. Nature 1983; 306 (5938): 32-36
27. Kotani Y, Hirota Y, Sugiyama K et al. Effects of noxious stimuli and anesthetic agents on substance P content in rat central nervous system. Jpn J Pharmacol 1986; 40 (1): 143-147
28. Hua XY, Theodorsson-Norheim E, Brodin E et al. Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig. Regul Pept 1985; 13 (1): 1-19
29. Dinh QT, Groneberg DA, Peiser C et al. Expression of substance P and nitric oxide synthase in vagal sensory neurons innervating the mouse airways. Regul Pept 2005; 126 (3): 189-194
30. Dinh QT, Mingomataj E, Quarcoo D et al. Allergic airway inflammation induces tachykinin peptides expression in vagal sensory neurons innervating mouse airways. Clin Exp Allergy 2005; 35 (6): 820-825
31. Kollarik M, Dinh QT, Fischer A et al. Capsaicin-sensitive and -insensitive vagal bronchopulmonary C-fibres in the mouse. J Physiol 2003; 551 (3): 869-879
32. Dinh QT, Groneberg DA, Peiser C et al. Substance P expression in TRPV1 and trkA-positive dorsal root ganglion neurons innervating the mouse lung. Respir Physiol Neurobiol 2004; 144(1): 15-24
33. Hunter DD, Myers AC, Undem BJ. Nerve growth factor-induced phenotypic switch in guinea pig airway sensory neurons. Am J Respir Crit Care Med 2000; 161 (6): 1985-1990
34. Myers AC, Kajekar R, Undem BJ. Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways. Am J Physiol Lung Cell Mol Physiol 2002; 282 (4): L775-781
35. Undem BJ, Hunter DD, Liu M et al. Allergen-induced sensory neuroplasticity in airways. Int Arch Allergy Immunol 1999; 118 (2-4): 150-153
36. Sikora ER, Stone S, Tomblyn S et al. Asphalt exposure enhances neuropeptide levels in sensory neurons projecting to the rat nasal epithelium. J Toxicol Environ Health 2003; 66 (11): 1015-1027
37. Hunter DD, Satterfield BE, Huang J et al. Toluene diisocyanate enhances substance P in sensory neurons innervating the nasal mucosa. Am J Respir Crit Care Med 2000; 161 (2 Pt 1): 543-549
38. Dinh QT, Groneberg DA, Mingomataj E et al. Expression of substance P and vanilloid receptor (VR1) in trigeminal sensory neurons projecting to the mouse nasal mucosa. Neuropeptides 2003; 37 (4): 245-250
39. Dinh QT, Groneberg DA, Witt C et al. Expression of Tyrosine Hydroxylase and Neuropeptide Tyrosine in Mouse Sympathetic Airway-specific Neurons under Normal Situation and Allergic Airway Inflammation. Clin Exp Allergy 2004; 34 (9): 1934-1941
40. Helke CJ, Krause JE, Mantyh PW et al. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms. Faseb J 1990; 4 (6): 1606-1615
41. Fischer A, Kummer W, Couraud JY et al. Immunohistochemical localization of receptors for vasoactive intestinal peptide and substance P in human trachea. Lab Invest 1992; 67 (3): 387-393
42. Canning BJ, Fischer A, Undem BJ. Pharmacological analysis of the tachykinin receptors that mediate activation of nonadrenergic, noncholinergic relaxant nerves that innervate guinea pig trachealis. J Pharmacol Exp Ther 1998; 284(1): 370-377
43. Joos GF, Germonpre PR, Pauwels RA. Role of tachykinins in asthma. Allergy 2000; 55 (4): 321-337
44. Frossard N, Advenier C. Tachykinin receptors and the airways. Life Sci 1991; 49(26): 1941-1953
45. Joachim RA, Sagach V, Quarcoo D et al. Neurokinin-1 receptor mediates stress-exacerbated allergic airway inflammation and airway hyperresponsiveness in mice. Psychosom Med 2004; 66 (4): 564-571
46. Frossard N, Barnes PJ. Effect of tachykinins in small human airways. Neuropeptides 1991; 19 (3): 157-161
47. Crimi N, Oliveri R, Polosa R et al. Effect of oral terfenadine on broncho-constrictor response to inhaled neurokinin A and histamine in asthmatic subjects. Eur Respir J 1993; 6 (10): 1462-1467
48. Frossard N, Rhoden KJ, Barnes PJ. Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. J Pharmacol Exp Ther 1989; 248 (1): 292-298
49. Lei YH, Barnes PJ, Rogers DF. Inhibition of neurogenic plasma exudation in guinea-pig airways by CP-96,345, a new non-peptide NK1 receptor antagonist. Br J Pharmacol 1992; 105 (2): 261-262
50. Quarcoo D, Schulte-Herbruggen O, Lommatzsch M et al. Nerve growth factor induces increased airway inflammation via a neuropeptide-dependent mechanism in a transgenic animal model of allergic airway inflammation. Clin Exp Allergy 2004; 34(7): 1146-1151
51. Mazzone SB. Targeting tachykinins for the treatment of obstructive airways disease. Treat Respir Med 2004; 3 (4): 201-216
52. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22 (4): 672-688
53. Shimosegawa T, Foda HD, Said SI. [Met]enkephalin-Arg6-Gly7-Leu8- immunoreactive nerves in guinea-pig and rat lungs: distribution, origin, and co-existence with vasoactive intestinal polypeptide immunoreactivity. Neuroscience 1990; 36 (3): 737-750